Search

Search Constraints

You searched for: Author/Creator Teraoka, Yuji

Search Results

1. A novel cDNA‐uPA/SCID/Rag2−/−/Jak3−/− mouse model for hepatitis virus infection and reconstruction of human immune system. Issue 3 (12th January 2023)

2. Abatacept treatment for patients with severe acute hepatitis caused by hepatitis B virus infection—Pilot study. Issue 2 (29th November 2020)

3. Circulating cytokines and angiogenic factors based signature associated with the relative dose intensity during treatment in patients with advanced hepatocellular carcinoma receiving lenvatinib. (May 2020)

4. Clinical outcomes of stereotactic body radiotherapy for elderly patients with hepatocellular carcinoma. Issue 2 (24th June 2017)

5. Comparison of hepatic arterial infusion chemotherapy between 5‐fluorouracil‐based continuous infusion chemotherapy and low‐dose cisplatin monotherapy for advanced hepatocellular carcinoma. Issue 13 (23rd August 2018)

6. Construction of an anti-hepatitis B virus preS1 antibody and usefulness of preS1 measurement for chronic hepatitis B patients: Anti-HBV PreS1 antibody. Issue 3 (March 2022)

7. Efficacy and safety of daclatasvir plus asunaprevir therapy for chronic hepatitis C patients with renal dysfunction. Issue 4 (24th October 2016)

8. Efficacy and safety of edoxaban for treatment of portal vein thrombosis following danaparoid sodium in patients with liver cirrhosis. Issue 1 (27th April 2017)

9. Efficacy of glecaprevir and pibrentasvir treatment for genotype 1b hepatitis C virus drug resistance-associated variants in humanized mice. (14th June 2019)

10. Efficacy of glecaprevir and pibrentasvir treatment for genotype 1b hepatitis C virus drug resistance-associated variants in humanized mice. (14th June 2019)